Interpretation of Trailing Endpoints in Antifungal Susceptibility Testing by the National Committee for Clinical Laboratory Standards Method (Q34073047)
scientific article published on January 1, 1998
Language:
(P31) (Q13442814)
(P304) 153-156
(P407) (Q1860)
(P433) 1
(P478) 36
(P577) Thursday, January 1, 1998
Thursday, January 1, 1998
(P921) (Q483242)
(P953) https://jcm.asm.org/content/jcm/36/1/153.full.pdf
http://intl-jcm.asm.org/cgi/content/abstract/36/1/153
https://europepmc.org/articles/PMC124826
https://europepmc.org/articles/PMC124826?pdf=render
https://journals.asm.org/doi/pdf/10.1128/JCM.36.1.153-156.1998
(P1433) (Q4041880)
(P1476) "Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method" (language: en)
"Interpretation of Trailing Endpoints in Antifungal Susceptibility Testing by the National Committee for Clinical Laboratory Standards Method" (language: en)
(P2093) S. G. Revankar
W. R. Kirkpatrick
R. K. McAtee
A. W. Fothergill
S. W. Redding
M. G. Rinaldi
T. F. Patterson
(P2860) (Q36855581)
(Q36542312)
(Q35128351)
(Q36535673)
(Q35900199)
(Q54215184)
(Q37222461)
(Q37229328)
(Q40619485)
(Q50269067)
(Q36521532)
other details
description scientific article published on January 1, 1998

External Links